67
Participants
Start Date
October 31, 2011
Primary Completion Date
December 31, 2014
Study Completion Date
December 31, 2014
Norzyme
Patients will be randomized to receive either pancreatic enzyme replacement therapy or placebo. Patients will use two capsules three times daily during main meals and one capsule three times daily during in between snacks. The pancreatic enzyme preparation under investigation is Norzyme ® 6 - 9 tablets per day.
NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,, Goyang-si
Collaborators (1)
Pharmbio Korea Co., Ltd.
INDUSTRY
National Cancer Center, Korea
OTHER_GOV